1. Mortality in rheumatoid arthritis: 2008 update;Sokka T;Clin Exp Rheumatol,2008
2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease‐modifying antirheumatic drugs: 2016 update;Smolen JS;Ann Rheum Dis,2017
3. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh JA;Arthritis Care Res (Hoboken),2016
4. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update;Goswami RP;Ann Rheum Dis,2016
5. Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, disease activity score (DAS) and disease activity score with 28‐joint counts (DAS28), simplified disease activity index (SDAI), clinical disease activity index (CDAI), patient activity score (PAS) and patient activity score‐II (PASII), routine assessment of patient index data (RAPID), rheumatoid arthritis disease activity index (RADAI) and rheumatoid arthritis disease activity index‐5 (RADAI‐5), chronic arthritis systemic index (CASI), patient‐based disease activity score with ESR (PDAS1) and patient‐based disease activity score without ESR (PDAS2), and mean overall index for rheumatoid arthritis (MOI‐RA);Anderson JK;Arthritis Care Res (Hoboken),2011